Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NTP-CERHR expert panel report on the reproductive and developmental toxicity of soy formula.
Rozman KK, Bhatia J, Calafat AM, Chambers C, Culty M, Etzel RA, Flaws JA, Hansen DK, Hoyer PB, Jeffery EH, Kesner JS, Marty S, Thomas JA, Umbach D. Rozman KK, et al. Among authors: hansen dk. Birth Defects Res B Dev Reprod Toxicol. 2006 Aug;77(4):280-397. doi: 10.1002/bdrb.20086. Birth Defects Res B Dev Reprod Toxicol. 2006. PMID: 16998908 Free PMC article. Review. No abstract available.
NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein.
Rozman KK, Bhatia J, Calafat AM, Chambers C, Culty M, Etzel RA, Flaws JA, Hansen DK, Hoyer PB, Jeffery EH, Kesner JS, Marty S, Thomas JA, Umbach D. Rozman KK, et al. Among authors: hansen dk. Birth Defects Res B Dev Reprod Toxicol. 2006 Dec;77(6):485-638. doi: 10.1002/bdrb.20087. Birth Defects Res B Dev Reprod Toxicol. 2006. PMID: 17186522 Free PMC article. Review. No abstract available.
Evaluation of the BBMEC model for screening the CNS permeability of drugs.
Otis KW, Avery ML, Broward-Partin SM, Hansen DK, Behlow HW Jr, Scott DO, Thompson TN. Otis KW, et al. Among authors: hansen dk. J Pharmacol Toxicol Methods. 2001 Jan-Feb;45(1):71-7. doi: 10.1016/s1056-8719(01)00120-4. J Pharmacol Toxicol Methods. 2001. PMID: 11489667 Review.
Toxicity of CAR T-Cell Therapy for Multiple Myeloma.
Afrough A, Abraham PR, Turer L, Kaur G, Sannareddy A, Hansen DK, Anderson LD Jr. Afrough A, et al. Among authors: hansen dk. Acta Haematol. 2024 May 8. doi: 10.1159/000539134. Online ahead of print. Acta Haematol. 2024. PMID: 38718775 Review.
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium.
Afrough A, Hashmi H, Hansen DK, Sidana S, Ahn C, Peres LC, Dima D, Freeman CL, Puglianini OC, Kocoglu MH, Atrash S, Voorhees PM, Shune L, McGuirk JP, Simmons G, Sborov DW, Davis JA, Kaur G, Sannareddy A, Ferreri CJ, Gaballa MR, Goldsmith S, Nadeem O, Midha S, Wagner CB, Locke FL, Patel KK, Khouri J, Anderson LD Jr, Lin Y. Afrough A, et al. Among authors: hansen dk. Blood Cancer J. 2024 Apr 12;14(1):63. doi: 10.1038/s41408-024-00993-0. Blood Cancer J. 2024. PMID: 38609386 Free PMC article. No abstract available.
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality.
Rejeski K, Wang Y, Hansen DK, Iacoboni G, Bachy E, Bansal R, Penack O, Müller F, Bethge W, Munoz J, Mohty R, Bücklein VL, Barba P, Locke FL, Lin Y, Jain MD, Subklewe M. Rejeski K, et al. Among authors: hansen dk. Blood Adv. 2024 Apr 23;8(8):1857-1868. doi: 10.1182/bloodadvances.2023011767. Blood Adv. 2024. PMID: 38181508 Free PMC article.
114 results